Table 2.

Most prevalent therapeutic classes among the study population (n=8932)

Medication therapy class	N	%
Oral antidiabetic agent	7270	81.4
Non-steroidal anti-inflammatory drugs	6467	72.4
Antihyperlipidaemic agents	6144	68.8
Proton pump inhibitor	2540	28.4
ACE inhibitor	2321	25.9
Injectable antidiabetic agent	2253	25.2
Calcium channel blocker	2162	24.2
Corticosteroid, local	1892	21.1
Diuretic	1934	21.6
Beta-adrenergic blocker, beta-1 selective	1806	20.2
Angiotensin II receptor blocker	1796	20.1
Thyroid analogue	1355	15.1
Histamine H2 blocker	822	9.2
Anticoagulants	706	7.9
Corticosteroid, systemic	600	6.7
Antiplatelet	357	4.0